PayPal is expected to report a year-over-year earnings decline for Q1 2026 despite higher revenues, amid ongoing competitive pressures and leadership changes. The company is rolling out new ...
The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics Lic ...
The first Galaxy Buds 4 and Buds 4 Pro update brings stability fixes for select regions, for now. Users are beginning to see ...
The SYNCHRONIZE-1 trial evaluated survodutide in non-diabetic adults with obesity or overweight with at least 1 weight-related complication.
Phase 2/3 trial data show VDPHL01, an oral non-hormonal extended-release minoxidil, improves hair growth and patient-reported outcomes in male pattern hair loss.
Coramitug is currently being investigated in the phase 3 CLEOPATTRA trial in approximately 1280 patients with ATTR-CM.
The Fuel Subsidy Support Scheme will provide €20 million per month in supports, with funding directly linked to fuel usage ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
FDA issues a Complete Response Letter to Grace Therapeutics for GTx-104, an intravenous nimodipine formulation for aneurysmal subarachnoid hemorrhage.
The FDA has granted Fast Track designation to KT-621, a first-in-class oral STAT6 degrader for moderate to severe ...
Even though facial recognition templates are more secure than photos -- which anyone can capture and manipulate -- templates, ...
Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results